 | • レポートコード：MRC2Q12-03360 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、ビガバトリンAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にビガバトリンAPIのグローバル市場のxxx％を占める「98%以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 ビガバトリンAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのビガバトリンAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ビガバトリンAPIのグローバル主要プレイヤーには、Hetero Drugs、Aurobindo Pharma Limited、Intas Pharmaceuticals、Metrochem API Private Limited、SMS Pharmaceuticals、Biophore India Pharmaceuticals Pvt Ltd、Divis Laboratories Ltd.、Granules India Limited、Guangzhou Tosun Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ビガバトリンAPI市場は、種類と用途によって区分されます。世界のビガバトリンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 98%以上、99%以上 【用途別セグメント】 錠剤、内服液、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ビガバトリンAPI製品概要 - 種類別市場（98%以上、99%以上） - 用途別市場（錠剤、内服液、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のビガバトリンAPI販売量予測2017-2028 - 世界のビガバトリンAPI売上予測2017-2028 - ビガバトリンAPIの地域別販売量 - ビガバトリンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ビガバトリンAPI販売量 - 主要メーカー別ビガバトリンAPI売上 - 主要メーカー別ビガバトリンAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（98%以上、99%以上） - ビガバトリンAPIの種類別販売量 - ビガバトリンAPIの種類別売上 - ビガバトリンAPIの種類別価格 ・用途別市場規模（錠剤、内服液、その他） - ビガバトリンAPIの用途別販売量 - ビガバトリンAPIの用途別売上 - ビガバトリンAPIの用途別価格 ・北米市場 - 北米のビガバトリンAPI市場規模（種類別、用途別） - 主要国別のビガバトリンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのビガバトリンAPI市場規模（種類別、用途別） - 主要国別のビガバトリンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のビガバトリンAPI市場規模（種類別、用途別） - 主要国別のビガバトリンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のビガバトリンAPI市場規模（種類別、用途別） - 主要国別のビガバトリンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのビガバトリンAPI市場規模（種類別、用途別） - 主要国別のビガバトリンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hetero Drugs、Aurobindo Pharma Limited、Intas Pharmaceuticals、Metrochem API Private Limited、SMS Pharmaceuticals、Biophore India Pharmaceuticals Pvt Ltd、Divis Laboratories Ltd.、Granules India Limited、Guangzhou Tosun Pharmaceutical ・産業チェーン及び販売チャネル分析 - ビガバトリンAPIの産業チェーン分析 - ビガバトリンAPIの原材料 - ビガバトリンAPIの生産プロセス - ビガバトリンAPIの販売及びマーケティング - ビガバトリンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ビガバトリンAPIの産業動向 - ビガバトリンAPIのマーケットドライバー - ビガバトリンAPIの課題 - ビガバトリンAPIの阻害要因 ・主な調査結果 |
Vigabatrin(CAS：60643-86-9) is a gamma-amino acid having a gamma-vinyl GABA structure.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Vigabatrin API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Vigabatrin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Vigabatrin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Vigabatrin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Vigabatrin API include Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited and Guangzhou Tosun Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Vigabatrin API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Vigabatrin API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Vigabatrin API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Vigabatrin API market. Further, it explains the major drivers and regional dynamics of the global Vigabatrin API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt Ltd
Divis Laboratories Ltd.
Granules India Limited
Guangzhou Tosun Pharmaceutical
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Vigabatrin API Segment by Purity
Above 98 %
Above 99 %
Vigabatrin API Segment by Application
Tablets
Oral Solution
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Vigabatrin API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Vigabatrin API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Vigabatrin API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Vigabatrin API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Vigabatrin API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vigabatrin API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Vigabatrin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Vigabatrin API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited and Guangzhou Tosun Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Vigabatrin API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Vigabatrin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Vigabatrin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vigabatrin API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Vigabatrin API Product Introduction
1.2 Market by Purity
1.2.1 Global Vigabatrin API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Market by Application
1.3.1 Global Vigabatrin API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Vigabatrin API Production
2.1 Global Vigabatrin API Production Capacity (2017-2028)
2.2 Global Vigabatrin API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Vigabatrin API Production by Region
2.3.1 Global Vigabatrin API Historic Production by Region (2017-2022)
2.3.2 Global Vigabatrin API Forecasted Production by Region (2023-2028)
2.4 India
2.5 China
3 Global Vigabatrin API Sales in Volume & Value Estimates and Forecasts
3.1 Global Vigabatrin API Sales Estimates and Forecasts 2017-2028
3.2 Global Vigabatrin API Revenue Estimates and Forecasts 2017-2028
3.3 Global Vigabatrin API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Vigabatrin API Sales by Region
3.4.1 Global Vigabatrin API Sales by Region (2017-2022)
3.4.2 Global Sales Vigabatrin API by Region (2023-2028)
3.5 Global Vigabatrin API Revenue by Region
3.5.1 Global Vigabatrin API Revenue by Region (2017-2022)
3.5.2 Global Vigabatrin API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Vigabatrin API Production Capacity by Manufacturers
4.2 Global Vigabatrin API Sales by Manufacturers
4.2.1 Global Vigabatrin API Sales by Manufacturers (2017-2022)
4.2.2 Global Vigabatrin API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Vigabatrin API in 2021
4.3 Global Vigabatrin API Revenue by Manufacturers
4.3.1 Global Vigabatrin API Revenue by Manufacturers (2017-2022)
4.3.2 Global Vigabatrin API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Vigabatrin API Revenue in 2021
4.4 Global Vigabatrin API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vigabatrin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Vigabatrin API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Vigabatrin API Sales by Purity
5.1.1 Global Vigabatrin API Historical Sales by Purity (2017-2022)
5.1.2 Global Vigabatrin API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Vigabatrin API Sales Market Share by Purity (2017-2028)
5.2 Global Vigabatrin API Revenue by Purity
5.2.1 Global Vigabatrin API Historical Revenue by Purity (2017-2022)
5.2.2 Global Vigabatrin API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Vigabatrin API Revenue Market Share by Purity (2017-2028)
5.3 Global Vigabatrin API Price by Purity
5.3.1 Global Vigabatrin API Price by Purity (2017-2022)
5.3.2 Global Vigabatrin API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Vigabatrin API Sales by Application
6.1.1 Global Vigabatrin API Historical Sales by Application (2017-2022)
6.1.2 Global Vigabatrin API Forecasted Sales by Application (2023-2028)
6.1.3 Global Vigabatrin API Sales Market Share by Application (2017-2028)
6.2 Global Vigabatrin API Revenue by Application
6.2.1 Global Vigabatrin API Historical Revenue by Application (2017-2022)
6.2.2 Global Vigabatrin API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Vigabatrin API Revenue Market Share by Application (2017-2028)
6.3 Global Vigabatrin API Price by Application
6.3.1 Global Vigabatrin API Price by Application (2017-2022)
6.3.2 Global Vigabatrin API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Vigabatrin API Market Size by Purity
7.1.1 North America Vigabatrin API Sales by Purity (2017-2028)
7.1.2 North America Vigabatrin API Revenue by Purity (2017-2028)
7.2 North America Vigabatrin API Market Size by Application
7.2.1 North America Vigabatrin API Sales by Application (2017-2028)
7.2.2 North America Vigabatrin API Revenue by Application (2017-2028)
7.3 North America Vigabatrin API Sales by Country
7.3.1 North America Vigabatrin API Sales by Country (2017-2028)
7.3.2 North America Vigabatrin API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Vigabatrin API Market Size by Purity
8.1.1 Europe Vigabatrin API Sales by Purity (2017-2028)
8.1.2 Europe Vigabatrin API Revenue by Purity (2017-2028)
8.2 Europe Vigabatrin API Market Size by Application
8.2.1 Europe Vigabatrin API Sales by Application (2017-2028)
8.2.2 Europe Vigabatrin API Revenue by Application (2017-2028)
8.3 Europe Vigabatrin API Sales by Country
8.3.1 Europe Vigabatrin API Sales by Country (2017-2028)
8.3.2 Europe Vigabatrin API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Vigabatrin API Market Size by Purity
9.1.1 Asia Pacific Vigabatrin API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Vigabatrin API Revenue by Purity (2017-2028)
9.2 Asia Pacific Vigabatrin API Market Size by Application
9.2.1 Asia Pacific Vigabatrin API Sales by Application (2017-2028)
9.2.2 Asia Pacific Vigabatrin API Revenue by Application (2017-2028)
9.3 Asia Pacific Vigabatrin API Sales by Region
9.3.1 Asia Pacific Vigabatrin API Sales by Region (2017-2028)
9.3.2 Asia Pacific Vigabatrin API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Vigabatrin API Market Size by Purity
10.1.1 Latin America Vigabatrin API Sales by Purity (2017-2028)
10.1.2 Latin America Vigabatrin API Revenue by Purity (2017-2028)
10.2 Latin America Vigabatrin API Market Size by Application
10.2.1 Latin America Vigabatrin API Sales by Application (2017-2028)
10.2.2 Latin America Vigabatrin API Revenue by Application (2017-2028)
10.3 Latin America Vigabatrin API Sales by Country
10.3.1 Latin America Vigabatrin API Sales by Country (2017-2028)
10.3.2 Latin America Vigabatrin API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vigabatrin API Market Size by Purity
11.1.1 Middle East and Africa Vigabatrin API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Vigabatrin API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Vigabatrin API Market Size by Application
11.2.1 Middle East and Africa Vigabatrin API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Vigabatrin API Revenue by Application (2017-2028)
11.3 Middle East and Africa Vigabatrin API Sales by Country
11.3.1 Middle East and Africa Vigabatrin API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Vigabatrin API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hetero Drugs
12.1.1 Hetero Drugs Corporation Information
12.1.2 Hetero Drugs Overview
12.1.3 Hetero Drugs Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hetero Drugs Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hetero Drugs Recent Developments
12.2 Aurobindo Pharma Limited
12.2.1 Aurobindo Pharma Limited Corporation Information
12.2.2 Aurobindo Pharma Limited Overview
12.2.3 Aurobindo Pharma Limited Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Aurobindo Pharma Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Aurobindo Pharma Limited Recent Developments
12.3 Intas Pharmaceuticals
12.3.1 Intas Pharmaceuticals Corporation Information
12.3.2 Intas Pharmaceuticals Overview
12.3.3 Intas Pharmaceuticals Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Intas Pharmaceuticals Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Intas Pharmaceuticals Recent Developments
12.4 Metrochem API Private Limited
12.4.1 Metrochem API Private Limited Corporation Information
12.4.2 Metrochem API Private Limited Overview
12.4.3 Metrochem API Private Limited Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Metrochem API Private Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Metrochem API Private Limited Recent Developments
12.5 SMS Pharmaceuticals
12.5.1 SMS Pharmaceuticals Corporation Information
12.5.2 SMS Pharmaceuticals Overview
12.5.3 SMS Pharmaceuticals Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 SMS Pharmaceuticals Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 SMS Pharmaceuticals Recent Developments
12.6 Biophore India Pharmaceuticals Pvt Ltd
12.6.1 Biophore India Pharmaceuticals Pvt Ltd Corporation Information
12.6.2 Biophore India Pharmaceuticals Pvt Ltd Overview
12.6.3 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments
12.7 Divis Laboratories Ltd.
12.7.1 Divis Laboratories Ltd. Corporation Information
12.7.2 Divis Laboratories Ltd. Overview
12.7.3 Divis Laboratories Ltd. Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Divis Laboratories Ltd. Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Divis Laboratories Ltd. Recent Developments
12.8 Granules India Limited
12.8.1 Granules India Limited Corporation Information
12.8.2 Granules India Limited Overview
12.8.3 Granules India Limited Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Granules India Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Granules India Limited Recent Developments
12.9 Guangzhou Tosun Pharmaceutical
12.9.1 Guangzhou Tosun Pharmaceutical Corporation Information
12.9.2 Guangzhou Tosun Pharmaceutical Overview
12.9.3 Guangzhou Tosun Pharmaceutical Vigabatrin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Guangzhou Tosun Pharmaceutical Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Guangzhou Tosun Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vigabatrin API Industry Chain Analysis
13.2 Vigabatrin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vigabatrin API Production Mode & Process
13.4 Vigabatrin API Sales and Marketing
13.4.1 Vigabatrin API Sales Channels
13.4.2 Vigabatrin API Distributors
13.5 Vigabatrin API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Vigabatrin API Industry Trends
14.2 Vigabatrin API Market Drivers
14.3 Vigabatrin API Market Challenges
14.4 Vigabatrin API Market Restraints
15 Key Finding in The Global Vigabatrin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Vigabatrin API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 98 %
Table 3. Major Manufacturers of Above 99 %
Table 4. Global Vigabatrin API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Vigabatrin API Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 6. Global Vigabatrin API Production by Region (2017-2022) & (Kg)
Table 7. Global Vigabatrin API Production Market Share by Region (2017-2022)
Table 8. Global Vigabatrin API Production by Region (2023-2028) & (Kg)
Table 9. Global Vigabatrin API Production Market Share by Region (2023-2028)
Table 10. Global Vigabatrin API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Vigabatrin API Sales by Region (2017-2022) & (Kg)
Table 12. Global Vigabatrin API Sales Market Share by Region (2017-2022)
Table 13. Global Vigabatrin API Sales by Region (2023-2028) & (Kg)
Table 14. Global Vigabatrin API Sales Market Share by Region (2023-2028)
Table 15. Global Vigabatrin API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Vigabatrin API Revenue Market Share by Region (2017-2022)
Table 17. Global Vigabatrin API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Vigabatrin API Revenue Market Share by Region (2023-2028)
Table 19. Global Vigabatrin API Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 20. Global Vigabatrin API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Vigabatrin API Sales by Manufacturers (2017-2022) & (Kg)
Table 22. Global Vigabatrin API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Vigabatrin API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Vigabatrin API Revenue Share by Manufacturers (2017-2022)
Table 25. Vigabatrin API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Vigabatrin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Vigabatrin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vigabatrin API as of 2021)
Table 28. Vigabatrin API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Vigabatrin API Product Offered
Table 30. Date of Manufacturers Enter into Vigabatrin API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 33. Global Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 34. Global Vigabatrin API Sales Share by Purity (2017-2022)
Table 35. Global Vigabatrin API Sales Share by Purity (2023-2028)
Table 36. Global Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 37. Global Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 38. Global Vigabatrin API Revenue Share by Purity (2017-2022)
Table 39. Global Vigabatrin API Revenue Share by Purity (2023-2028)
Table 40. Vigabatrin API Price by Purity (2017-2022) & (US$/Kg)
Table 41. Global Vigabatrin API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 42. Global Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 43. Global Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 44. Global Vigabatrin API Sales Share by Application (2017-2022)
Table 45. Global Vigabatrin API Sales Share by Application (2023-2028)
Table 46. Global Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Vigabatrin API Revenue Share by Application (2017-2022)
Table 49. Global Vigabatrin API Revenue Share by Application (2023-2028)
Table 50. Vigabatrin API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Vigabatrin API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 53. North America Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 54. North America Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 55. North America Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 56. North America Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 57. North America Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 58. North America Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 61. North America Vigabatrin API Sales by Country (2023-2028) & (Kg)
Table 62. North America Vigabatrin API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Vigabatrin API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 65. Europe Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 66. Europe Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 67. Europe Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 68. Europe Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 69. Europe Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 70. Europe Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 73. Europe Vigabatrin API Sales by Country (2023-2028) & (Kg)
Table 74. Europe Vigabatrin API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Vigabatrin API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 77. Asia Pacific Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 78. Asia Pacific Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 79. Asia Pacific Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 80. Asia Pacific Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 81. Asia Pacific Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 82. Asia Pacific Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Vigabatrin API Sales by Region (2017-2022) & (Kg)
Table 85. Asia Pacific Vigabatrin API Sales by Region (2023-2028) & (Kg)
Table 86. Asia Pacific Vigabatrin API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Vigabatrin API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 89. Latin America Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 90. Latin America Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 91. Latin America Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 92. Latin America Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 93. Latin America Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 94. Latin America Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 97. Latin America Vigabatrin API Sales by Country (2023-2028) & (Kg)
Table 98. Latin America Vigabatrin API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Vigabatrin API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Vigabatrin API Sales by Purity (2017-2022) & (Kg)
Table 101. Middle East and Africa Vigabatrin API Sales by Purity (2023-2028) & (Kg)
Table 102. Middle East and Africa Vigabatrin API Revenue by Purity (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Vigabatrin API Revenue by Purity (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Vigabatrin API Sales by Application (2017-2022) & (Kg)
Table 105. Middle East and Africa Vigabatrin API Sales by Application (2023-2028) & (Kg)
Table 106. Middle East and Africa Vigabatrin API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Vigabatrin API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Vigabatrin API Sales by Country (2017-2022) & (Kg)
Table 109. Middle East and Africa Vigabatrin API Sales by Country (2023-2028) & (Kg)
Table 110. Middle East and Africa Vigabatrin API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Vigabatrin API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Hetero Drugs Corporation Information
Table 113. Hetero Drugs Description and Major Businesses
Table 114. Hetero Drugs Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Hetero Drugs Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Hetero Drugs Recent Development
Table 117. Aurobindo Pharma Limited Corporation Information
Table 118. Aurobindo Pharma Limited Description and Major Businesses
Table 119. Aurobindo Pharma Limited Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Aurobindo Pharma Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Aurobindo Pharma Limited Recent Development
Table 122. Intas Pharmaceuticals Corporation Information
Table 123. Intas Pharmaceuticals Description and Major Businesses
Table 124. Intas Pharmaceuticals Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. Intas Pharmaceuticals Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Intas Pharmaceuticals Recent Development
Table 127. Metrochem API Private Limited Corporation Information
Table 128. Metrochem API Private Limited Description and Major Businesses
Table 129. Metrochem API Private Limited Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Metrochem API Private Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Metrochem API Private Limited Recent Development
Table 132. SMS Pharmaceuticals Corporation Information
Table 133. SMS Pharmaceuticals Description and Major Businesses
Table 134. SMS Pharmaceuticals Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. SMS Pharmaceuticals Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. SMS Pharmaceuticals Recent Development
Table 137. Biophore India Pharmaceuticals Pvt Ltd Corporation Information
Table 138. Biophore India Pharmaceuticals Pvt Ltd Description and Major Businesses
Table 139. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Biophore India Pharmaceuticals Pvt Ltd Recent Development
Table 142. Divis Laboratories Ltd. Corporation Information
Table 143. Divis Laboratories Ltd. Description and Major Businesses
Table 144. Divis Laboratories Ltd. Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Divis Laboratories Ltd. Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Divis Laboratories Ltd. Recent Development
Table 147. Granules India Limited Corporation Information
Table 148. Granules India Limited Description and Major Businesses
Table 149. Granules India Limited Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Granules India Limited Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Granules India Limited Recent Development
Table 152. Guangzhou Tosun Pharmaceutical Corporation Information
Table 153. Guangzhou Tosun Pharmaceutical Description and Major Businesses
Table 154. Guangzhou Tosun Pharmaceutical Vigabatrin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Guangzhou Tosun Pharmaceutical Vigabatrin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Guangzhou Tosun Pharmaceutical Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Vigabatrin API Distributors List
Table 160. Vigabatrin API Customers List
Table 161. Vigabatrin API Market Trends
Table 162. Vigabatrin API Market Drivers
Table 163. Vigabatrin API Market Challenges
Table 164. Vigabatrin API Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Vigabatrin API Product Picture
Figure 2. Global Vigabatrin API Market Share by Purity in 2021 & 2028
Figure 3. Above 98 % Product Picture
Figure 4. Above 99 % Product Picture
Figure 5. Global Vigabatrin API Market Share by Application in 2021 & 2028
Figure 6. Tablets
Figure 7. Oral Solution
Figure 8. Others
Figure 9. Vigabatrin API Report Years Considered
Figure 10. Global Vigabatrin API Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 11. Global Vigabatrin API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Vigabatrin API Production Market Share by Region (2017-2022)
Figure 13. Global Vigabatrin API Production Market Share by Region (2023-2028)
Figure 14. Vigabatrin API Production Growth Rate in India (2017-2028) & (Kg)
Figure 15. Vigabatrin API Production Growth Rate in China (2017-2028) & (Kg)
Figure 16. Global Vigabatrin API Sales 2017-2028 (Kg)
Figure 17. Global Vigabatrin API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Vigabatrin API Revenue 2017-2028 (US$ Million)
Figure 19. Global Vigabatrin API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Vigabatrin API Sales Market Share by Region (2017-2022)
Figure 21. Global Vigabatrin API Sales Market Share by Region (2023-2028)
Figure 22. North America Vigabatrin API Sales YoY (2017-2028) & (Kg)
Figure 23. North America Vigabatrin API Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Vigabatrin API Sales YoY (2017-2028) & (Kg)
Figure 25. Europe Vigabatrin API Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Vigabatrin API Sales YoY (2017-2028) & (Kg)
Figure 27. Asia-Pacific Vigabatrin API Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Vigabatrin API Sales YoY (2017-2028) & (Kg)
Figure 29. Latin America Vigabatrin API Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Vigabatrin API Sales YoY (2017-2028) & (Kg)
Figure 31. Middle East & Africa Vigabatrin API Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Vigabatrin API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Vigabatrin API in the World: Market Share by Vigabatrin API Revenue in 2021
Figure 34. Vigabatrin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 36. Global Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 37. Global Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 38. Global Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 39. North America Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 40. North America Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 41. North America Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 42. North America Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 43. North America Vigabatrin API Sales Share by Country (2017-2028)
Figure 44. North America Vigabatrin API Revenue Share by Country (2017-2028)
Figure 45. United States Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 48. Europe Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 49. Europe Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 50. Europe Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 51. Europe Vigabatrin API Sales Share by Country (2017-2028)
Figure 52. Europe Vigabatrin API Revenue Share by Country (2017-2028)
Figure 53. Germany Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 54. France Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 59. Asia Pacific Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 60. Asia Pacific Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Vigabatrin API Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Vigabatrin API Revenue Share by Region (2017-2028)
Figure 64. China Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 67. India Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 74. Latin America Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 75. Latin America Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 76. Latin America Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Vigabatrin API Sales Share by Country (2017-2028)
Figure 78. Latin America Vigabatrin API Revenue Share by Country (2017-2028)
Figure 79. Mexico Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Vigabatrin API Sales Market Share by Purity (2017-2028)
Figure 83. Middle East and Africa Vigabatrin API Revenue Market Share by Purity (2017-2028)
Figure 84. Middle East and Africa Vigabatrin API Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Vigabatrin API Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Vigabatrin API Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Vigabatrin API Revenue Share by Country (2017-2028)
Figure 88. Turkey Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Vigabatrin API Revenue (2017-2028) & (US$ Million)
Figure 91. Vigabatrin API Value Chain
Figure 92. Vigabatrin API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed